The 1st Conference on Collaborative Working Environments for Business and Industry

May 10-11 2006, Brussels

In March 2000, the European Union agreed on a political vision aimed at making the EU the most dynamic and competitive knowledge-based economy in the world by 2010. The 'Lisbon Strategy' has reached half time with mixed results, leading to a renewed strategy focusing on 'delivering stronger and lasting growth and creating more and better jobs'. The revitalised strategy relates strongly to Information and Communication Technologies (ICT), specifically in the i2010 vision – radically modernising and deploying the EU policy instruments to encourage the development of the digital economy – and in the upcoming Seventh Framework Programme (FP7) for research and technological development (2007-2013).

The mission of the conference is to bring together a select group of industry practitioners and academics, to jointly address emerging industry needs, and to shape the future research agenda in the area of Collaborative Working Environments. More specifically, participants will contribute to defi ning key research themes for the forthcoming FP7 programmes in which collaborative environments are part of the application research area "ICT supporting business and industry". The conference will also act as a kick-off for projects approved under Call 5 of the IST Programme in FP6 on the area of "Collaborative Working Environments".

Please find all information, programmes and agendas and participation formalities of this conference at http://www.cwe-europe.org.

Most Popular Now

Significant Disparities in Telemedicine …

After "COVID-19," the term that most people will remember best from 2020 is likely to be "social distancing." While it most commonly applied to social gatherings with family and friends...

Model Used to Evaluate Lockdowns was Fla…

In a recent study, researchers from Imperial College London developed a model to assess the effect of different measures used to curb the spread of the coronavirus. However, the model...

New Virtual Screening Strategy Identifie…

A novel computational drug screening strategy combined with lab experiments suggest that pralatrexate, a chemotherapy medication originally developed to treat lymphoma, could potentially be repurposed to treat COVID-19. Haiping Zhang...

Using Artificial Intelligence to Find Ne…

Scientists have developed a machine-learning method that crunches massive amounts of data to help determine which existing medications could improve outcomes in diseases for which they are not prescribed. The intent...

FDA Releases Artificial Intelligence / M…

Today, the U.S. Food and Drug Administration released the agency's first Artificial Intelligence/Machine Learning (AI/ML)-Based Software as a Medical Device (SaMD) Action Plan. This action plan describes a multi-pronged approach...

One in Four Doctors Attacked, Harassed o…

While many physicians benefit from social media by networking with potential collaborators or interfacing with patients, a new study from Northwestern University and the University of Chicago found many physicians...

CliniSys Launches Laboratory Information…

CliniSys has launched a new laboratory information management system for genomic laboratories in the UK. The company has brought GLIMS Genomics to the UK from Europe, where it is being...

The Institute of Healthcare Management C…

The Institute of Healthcare Management has called for honest and open communication about NHS capacity after a snapshot survey revealed the scale of sickness absence across the service. The UK's leading...

First NHS Trust and Sectra Achieve Rapid…

A new region-wide approach to analysing x-rays, MRI scans, CT scans, mammography, and an entire range of crucial diagnostic images, has started to become reality, now that The Pennine Acute...

Bayer Transforms Pharma Business through…

At its virtual Pharma Media Day, Bayer presented exciting progress in transforming its pharmaceutical business with breakthrough innovation in healthcare that will significantly help patients suffering from conditions that are...

Abbott to Launch the NeuroSphere™ myPath…

Abbott (NYSE: ABT) today announced the upcoming launch of NeuroSphere™ myPath™, a digital health app designed to track and report on patient perceived pain relief and general well-being associated with...